BIT
GNCA

BlackRock Institutional Trust’s Genocea Biosciences, Inc. GNCA Stock Holding History

BlackRock Institutional Trust’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$896K Buy
27,181
+4,199
+18% +$138K ﹤0.01% 3319
2016
Q3 		$941K Hold
22,982
– – ﹤0.01% 3320
2016
Q2 		$754K Sell
22,982
-10,376
-31% -$380K ﹤0.01% 3404
2016
Q1 		$2.07M Sell
33,358
-391
-1% -$12.4K ﹤0.01% 3025
2015
Q4 		$1.42M Buy
33,749
+4,705
+16% +$224K ﹤0.01% 3233
2015
Q3 		$1.59M Buy
29,044
+14,175
+95% +$1.41M ﹤0.01% 3195
2015
Q2 		$1.63M Buy
14,869
+9,726
+189% +$903K ﹤0.01% 3192
2015
Q1 		$488K Buy
5,143
+1,145
+29% +$80.8K ﹤0.01% 3509
2014
Q4 		$224K Sell
3,998
-2,065
-34% -$141K ﹤0.01% 3627
2014
Q3 		$439K Sell
6,063
-368
-6% -$40.3K ﹤0.01% 3513
2014
Q2 		$965K Buy
6,431
+189
+3% +$28.7K ﹤0.01% 3443
2014
Q1 		$908K Buy
+6,242
New +$765K ﹤0.01% 3448

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

BlackRock Institutional Trust's GNCA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Genocea Biosciences, Inc. (GNCA) stake by 18% in Q4 2016, buying an estimated $138K and bringing the position to 27,181 shares worth $896K. The position accounts for ﹤0.01% of the portfolio, ranked #3319.

BlackRock Institutional Trust first reported a position in GNCA in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.07M in Q1 2016. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

  • BlackRock Institutional Trust held 27,181 shares of Genocea Biosciences, Inc. worth $896K as of Q4 2016.
  • BlackRock Institutional Trust bought 4,199 Genocea Biosciences, Inc. shares in Q4 2016, an estimated $138K.
  • Genocea Biosciences, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3319 holding.
  • BlackRock Institutional Trust first reported a position in Genocea Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Institutional Trust's Genocea Biosciences, Inc. position peaked at $2.07M in Q1 2016.
  • 47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.